VEGFA

(vascular endothelial growth factor A)

 

  • Alias                                 (According to NCBI)

 

  • RP1-261G23.1,
  • MGC70609,
  • VEGF,
  • VEGF-A,
  • VPF
  • vascular permeability factor
  • Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis, and induces permeabilization of blood vessels. Binds to the VEGFR1/Flt-1 and VEGFR2/Kdr receptors, heparan sulfate and heparin. Neuropilin-1 binds isoforms VEGF-165 and VEGF-145.
  • Location: 6p12
  • Size: 16272 bp
  • exons:
  • Transcript variant1: 8
  • Transcript variant2: 8
  • Transcript variant3: 8
  • Transcript variant4: 7
  • Transcript variant5: 7  
  • Transcript variant6: 6
  • Transcript variant7: 7
  • DNA sequence (Human): NC_000006.10

 

 

 

  • CGH (16p12):  Losses (%) -1.7   Gain (%)  7.0  

  • Mutations and SNPs (According to HGMD and SNP)

 

 

  • m-RNA                       (According to NCBI and CGAP)

 

  • mRNA sequence (Human):

  • Transcript variant1: NM_001025366.1

  • Transcript variant2: NM_003376.4

  • Transcript variant3: NM_001025367.1

  • Transcript variant4: NM_001025368.1

  • Transcript variant5: NM_001025369.1 

  • Transcript variant6: NM_001025370.1

  • Transcript variant7: NM_001033756.1

  • Size:

  • Transcript variant1: 3665 bp

  • Transcript variant2: 3614 bp

  • Transcript variant3: 3596 bp

  • Transcript variant4: 3542 bp

  • Transcript variant5: 3507 bp

  • Transcript variant6: 3410 bp

  • Transcript variant7: 3476 bp

  • cDNA libraries:

  • Size: 232 amino acids: 27042 Da
  • Catalytic activity:
  • Subcellular location: Secreted. Note=VEGF121 is acidic and freely secreted. VEGF165 is more basic, has heparin-binding properties and, although a signicant proportion remains cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated after secretion and is bound avidly by heparin and the extracellular matrix, although it may be released as a soluble form by heparin, heparinase or plasmin.

  • Protein domains

     

 

 

                        

  • Protein interactions: VEGF

  • Clinical                            (According to OMIM, PubMed)